Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Calvepen 333mg Tablets - PA0126/137/001
- Caverject 10mcg Powder and Solvent for Solution for Injection
- Cozaar 12.5mg Film Coated Tablets - PA23198/002/001
- Cytarabine 20mg/ml Solution for Injection or Infusion - PA0822/200/001
- Dioralyte Natural, Powder for Oral Solution - PA23180/007/001
- Dioralyte Rebalance Blackcurrant Powder for Oral Solution - PA23180/023/001
- Dioralyte Rebalance Citrus Powder for Oral Solution - PA23180/023/002
- Dioralyte Rebalance Natural Powder for Oral Solution - PA23180/023/003
- Dipentum 250mg Capsules - PA22657/001/001
- Dipentum 500mg Tablets - PA22657/001/002
- Estradot 75mcg/24 hours, Transdermal Patch - PA0896/010/003
- Estradot 100mcg/24 hours, Transdermal Patch - PA0896/010/004
- Flector Tissugel 140mg Medicated Plaster - PA1104/004/001
- Furosemide 10mg/ml Solution for Injection or Infusion (2ml presentation only) - PA2315/163/001
- Letrozole Teva 2.5mg Film Coated Tablets - PA0749/085/001
- Maxilief Effervescent Tablets (24 pack only) - PA0126/113/001
- Rapiscan 400mcg Solution for Injection - EU/1/10/643/001
- Rifadin 150mg Capsules - PA540/066/001
- RoActemra 20mg/ml Concentrate for Solution for Infusion - EU/1/08/492/001
- Yasmin 0.03mg/3mg Film Coated Tablets - PA1410/023/001
- Ziagen 20mg/ml Oral Solution - EU/1/99/112/002
- Zolmitriptan 2.5mg Orodispersible Tablets - PA2315/232/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Buscopan Ampoules 20mg/ml Solution for Injection - PA23180/016/001
- Canesten Combi Pessary & Cream - PA1410/039/001
- Innohep 10,000 IU in 0.5ml, Solution for Injection - PA0046/060/010
- Osteomel Once Weekly 70mg Tablets - PA0126/148/002
- Pregabalin Accord 75mg Hard Capsules - EU/1/15/1027/025
- Raporsin 8mg Prolonged Release Tablets - PA2315/005/001
- Triapin 5mg/5mg Prolonged Release Tablet - PA0540/082/002
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.